Masafumi Hashiguchi Selected Research

Antiviral Agents (Antivirals)

1/2022	Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.
1/2020	Hypovascular tumors developed into hepatocellular carcinoma at a high rate despite the elimination of hepatitis C virus by direct-acting antivirals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masafumi Hashiguchi Research Topics

Disease

3	Infections 01/2020 - 07/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 01/2017
1	Hemorrhage 06/2023
1	Dysuria 04/2021
1	Brain Diseases (Brain Disorder) 04/2021
1	Hyperammonemia 04/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Necrosis 01/2021
1	Liver Failure 01/2021
1	Adenocarcinoma 01/2017

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	daclatasvirIBA 01/2020 - 01/2018
2	asunaprevirIBA 01/2020 - 01/2018
1	UreaseIBA 04/2021
1	AmmoniaIBA 04/2021
1	Urea (Carbamide)FDA LinkGeneric 04/2021
1	durvalumabIBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	SteroidsIBA 01/2021
1	InterferonsIBA 01/2018
1	Nicardipine (Dagan)FDA LinkGeneric 07/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2017

Therapy/Procedure

5	Therapeutics 06/2023 - 07/2017
1	Gastrectomy 01/2017